Tag Archives: New England Peptide

Technology developed by the Atlantic Cancer Research Institute and New England Peptide Inc. to test patients for cancer and other diseases through bodily fluids instead of a tissue biopsy has caught global attention. ACRI has reached a licensing agreement with a ...

New England Peptide (NEP), a Massachusetts based biotech manufacturer, and The Atlantic Cancer Research Institute (ACRI), a leading cancer research center in Atlantic Canada, have launched a new biotech company. Excipio Technologies Inc. has a mandate to commercialize the Vn96 ...